Aquestive Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.

About AQST

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.

CEO

Daniel Barber

CEODaniel Barber

Employees

135

Employees135

Headquarters

Warren, New Jersey

HeadquartersWarren, New Jersey

Founded

2004

Founded2004

Employees

135

Employees135

AQST Key Statistics

Market cap

295.09M

Market cap295.09M

Price-Earnings ratio

-23.78

Price-Earnings ratio-23.78

Dividend yield

—

Dividend yield—

Average volume

3.25M

Average volume3.25M

High today

$3.41

High today$3.41

Low today

$3.21

Low today$3.21

Open price

$3.40

Open price$3.40

Volume

1.67M

Volume1.67M

52 Week high

$6.23

52 Week high$6.23

52 Week low

$1.25

52 Week low$1.25

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

Aquestive Therapeutics

Why Robinhood?

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. Show more

AQST Key Statistics

Analyst ratings

100%

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.